Michael King
Stock Analyst at EF Hutton
(1.00)
# 1,711
Out of 4,610 analysts
128
Total ratings
34.15%
Success rate
-16.82%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael King
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLM Apollomics | Maintains: Buy | $11 → $6.5 | $0.16 | +4,013.92% | 4 | Apr 1, 2024 | |
| SONN Sonnet BioTherapeutics Holdings | Assumes: Buy | $1,179 | $5.15 | +22,797.09% | 7 | Aug 23, 2023 | |
| LTRN Lantern Pharma | Reiterates: Buy | $11 | $3.77 | +191.78% | 10 | Aug 10, 2023 | |
| BMEA Biomea Fusion | Reiterates: Buy | $32 | $10.48 | +205.34% | 11 | Jun 26, 2023 | |
| JSPR Jasper Therapeutics | Reiterates: Buy | $69 | $16.08 | +326.00% | 10 | Jun 12, 2023 | |
| COEP Coeptis Therapeutics Holdings | Assumes: Buy | $10 | $0.17 | +5,683.69% | 7 | May 25, 2023 | |
| HOWL Werewolf Therapeutics | Assumes: Buy | $8.3 | $2.03 | +308.87% | 6 | May 25, 2023 | |
| REGN Regeneron Pharmaceuticals | Reiterates: Buy | $862 | $1,012.82 | -14.89% | 11 | May 1, 2023 | |
| EXEL Exelixis | Reiterates: Buy | $24 | $26.66 | -9.98% | 10 | Apr 28, 2023 | |
| OCEA Ocean Biomedical | Maintains: Buy | $10 → $17 | $0.91 | +1,765.88% | 3 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $166 | $4.87 | +3,308.62% | 8 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $19.85 | +111.59% | 5 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $304 | $267.99 | +13.44% | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $116 | $17.99 | +544.80% | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.93 | +433.68% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $28 | $0.73 | +3,735.62% | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $7.42 | +223.45% | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,000 → $800 | $1.41 | +56,637.59% | 2 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $46 | $33.98 | +35.37% | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $96 | $41.33 | +132.30% | 6 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $150 | $0.21 | +70,990.05% | 2 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $0.78 | +4,515.38% | 1 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.54 | +2,128.83% | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $11.11 | +179.03% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $180 → $160 | $1.96 | +8,063.27% | 4 | Oct 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $33 → $36 | $529.95 | -93.21% | 2 | Nov 13, 2017 |
Apollomics
Apr 1, 2024
Maintains: Buy
Price Target: $11 → $6.5
Current: $0.16
Upside: +4,013.92%
Sonnet BioTherapeutics Holdings
Aug 23, 2023
Assumes: Buy
Price Target: $1,179
Current: $5.15
Upside: +22,797.09%
Lantern Pharma
Aug 10, 2023
Reiterates: Buy
Price Target: $11
Current: $3.77
Upside: +191.78%
Biomea Fusion
Jun 26, 2023
Reiterates: Buy
Price Target: $32
Current: $10.48
Upside: +205.34%
Jasper Therapeutics
Jun 12, 2023
Reiterates: Buy
Price Target: $69
Current: $16.08
Upside: +326.00%
Coeptis Therapeutics Holdings
May 25, 2023
Assumes: Buy
Price Target: $10
Current: $0.17
Upside: +5,683.69%
Werewolf Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $8.3
Current: $2.03
Upside: +308.87%
Regeneron Pharmaceuticals
May 1, 2023
Reiterates: Buy
Price Target: $862
Current: $1,012.82
Upside: -14.89%
Exelixis
Apr 28, 2023
Reiterates: Buy
Price Target: $24
Current: $26.66
Upside: -9.98%
Ocean Biomedical
Apr 27, 2023
Maintains: Buy
Price Target: $10 → $17
Current: $0.91
Upside: +1,765.88%
Mar 28, 2023
Reiterates: Buy
Price Target: $166
Current: $4.87
Upside: +3,308.62%
Feb 24, 2023
Reiterates: Buy
Price Target: $42
Current: $19.85
Upside: +111.59%
Feb 24, 2023
Reiterates: Buy
Price Target: $304
Current: $267.99
Upside: +13.44%
Feb 24, 2023
Maintains: Buy
Price Target: $123 → $116
Current: $17.99
Upside: +544.80%
Dec 16, 2022
Initiates: Buy
Price Target: $10
Current: $1.93
Upside: +433.68%
Mar 30, 2022
Maintains: Buy
Price Target: $25 → $28
Current: $0.73
Upside: +3,735.62%
Mar 23, 2022
Initiates: Buy
Price Target: $24
Current: $7.42
Upside: +223.45%
Mar 11, 2022
Maintains: Buy
Price Target: $1,000 → $800
Current: $1.41
Upside: +56,637.59%
Mar 8, 2022
Maintains: Buy
Price Target: $43 → $46
Current: $33.98
Upside: +35.37%
Mar 3, 2022
Maintains: Buy
Price Target: $98 → $96
Current: $41.33
Upside: +132.30%
Jan 20, 2022
Maintains: Buy
Price Target: $300 → $150
Current: $0.21
Upside: +70,990.05%
Jan 10, 2022
Initiates: Buy
Price Target: $36
Current: $0.78
Upside: +4,515.38%
Dec 23, 2021
Initiates: Buy
Price Target: $12
Current: $0.54
Upside: +2,128.83%
Nov 5, 2021
Maintains: Buy
Price Target: $25 → $31
Current: $11.11
Upside: +179.03%
Oct 18, 2019
Maintains: Market Outperform
Price Target: $180 → $160
Current: $1.96
Upside: +8,063.27%
Nov 13, 2017
Maintains: Market Outperform
Price Target: $33 → $36
Current: $529.95
Upside: -93.21%